MCM
TMO icon

Maple Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Maple Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$272K Hold
554
– – 0.02% 97
2025
Q4 		$321K Buy
554
+10
+2% +$5.66K 0.02% 96
2025
Q3 		$264K Hold
544
– – 0.02% 97
2025
Q2 		$221K Sell
544
-17
-3% -$7.11K 0.02% 109
2025
Q1 		$279K Sell
561
-53
-9% -$28.7K 0.02% 99
2024
Q4 		$319K Sell
614
-32
-5% -$17.6K 0.02% 93
2024
Q3 		$400K Sell
646
-39
-6% -$23.1K 0.03% 81
2024
Q2 		$379K Buy
685
+5
+0.7% +$2.86K 0.03% 87
2024
Q1 		$395K Buy
+680
New +$382K 0.04% 78
2022
Q1 		– Sell
-301
Closed -$201K – 111
2021
Q4 		$201K Sell
301
-225
-43% -$140K 0.02% 105
2021
Q3 		$301K Hold
526
– – 0.04% 84
2021
Q2 		$286K Buy
526
+17
+3% +$8.02K 0.03% 88
2021
Q1 		$232K Buy
509
+18
+4% +$8.59K 0.03% 89
2020
Q4 		$229K Sell
491
-4
-0.8% -$1.88K 0.04% 90
2020
Q3 		$242K Sell
495
-176
-26% -$72.7K 0.04% 93
2020
Q2 		$243K Sell
671
-644
-49% -$216K 0.05% 90
2020
Q1 		$373K Sell
1,315
-339
-20% -$107K 0.09% 71
2019
Q4 		$537K Hold
1,654
– – 0.1% 78
2019
Q3 		$482K Sell
1,654
-162
-9% -$46.4K 0.1% 77
2019
Q2 		$533K Sell
1,816
-678
-27% -$187K 0.12% 74
2019
Q1 		$683K Sell
2,494
-180
-7% -$44.8K 0.16% 62
2018
Q4 		$598K Sell
2,674
-25
-0.9% -$5.87K 0.15% 70
2018
Q3 		$659K Sell
2,699
-405
-13% -$93.2K 0.15% 73
2018
Q2 		$643K Sell
3,104
-800
-20% -$170K 0.16% 70
2018
Q1 		$806K Buy
3,904
+675
+21% +$142K 0.2% 69
2017
Q4 		$613K Buy
3,229
+450
+16% +$86.2K 0.16% 77
2017
Q3 		$526K Buy
2,779
+504
+22% +$91.3K 0.14% 78
2017
Q2 		$397K Buy
2,275
+138
+6% +$23.2K 0.11% 94
2017
Q1 		$328K Buy
2,137
+453
+27% +$69.2K 0.1% 109
2016
Q4 		$238K Buy
1,684
+290
+21% +$42.8K 0.07% 117
2016
Q3 		$222K Buy
+1,394
New +$215K 0.07% 118

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Maple Capital Management's TMO Position: Q1 2026 in Review

Maple Capital Management held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 554 shares worth $272K. The position accounts for 0.02% of the portfolio, ranked #97.

Maple Capital Management first reported a position in TMO in Q3 2016 and has held it in 31 quarters since. The position peaked at $806K in Q1 2018. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Maple Capital Management held 554 shares of Thermo Fisher Scientific worth $272K as of Q1 2026.
  • Maple Capital Management left its Thermo Fisher Scientific share count unchanged in Q1 2026.
  • Thermo Fisher Scientific made up 0.02% of Maple Capital Management's portfolio in Q1 2026, its #97 holding.
  • Maple Capital Management first reported a position in Thermo Fisher Scientific in Q3 2016 and has held it in 31 quarters since.
  • Maple Capital Management's Thermo Fisher Scientific position peaked at $806K in Q1 2018.
  • 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Maple Capital Management's 13F filing for Q1 2026, filed 8 May 2026.